Project aims to raise awareness for pain research.
In an effort to educate the public about pain research and its impact on over 51.6 million Americans living with chronic pain, the US Pain Foundation has started an initiative to highlight the need for more research to improve outcomes. Titled #PainTrials, the endeavor will focus on current pain research efforts — including those being conducted through the National Institutes of Health's Helping to End Addiction Long-term® (HEAL) initiative.
According to a company press release, the organization hopes to:
"This month, we are excited to delve into the importance of pain research, and the impact research has on improved health outcomes for the millions of Americans living with the daily challenges of chronic pain," said Nicole Hemmenway, CEO, the US Pain Foundation. "We are excited to collaborate with the NIH HEAL Initiative, prominent researchers, and Humana to share the importance of pain research. A greater focus on research is vital to increase understanding and action surrounding chronic pain."
Reference: #PainTrials Initiative Seeks To Raise Awareness About The Need For Pain Research. PR Newswire. September 1, 2023. Accessed September 8, 2023. https://www.prnewswire.com/news-releases/paintrials-initiative-seeks-to-raise-awareness-about-the-need-for-pain-research-301914228.html
Talvey Plus Tecvayli Shows Promising Results in Multiple Myeloma but Raises Infection Concerns
January 9th 2025A Phase Ib/II dose escalation and expansion trial shows promising antitumor activity and durable responses with Talvey (talquetamab) plus Tecvayli (teclistamab) in the treatment of relapsed or refractory multiple myeloma, but a higher incidence of grade 3 or 4 infections.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.